Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients |
Park, Hoon Suk
(Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine)
Hong, Yuah (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Sun, In O (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Chung, Byung Ha (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Hyung Wook (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Choi, Bum Soon (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Park, Cheol Whee (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Jin, Dong Chan (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Kim, Yong Soo (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) Yang, Chul Woo (Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea College of Medicine) |
1 | Gohh RY, Yango AF, Morrissey PE, et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am J Transplant 2005;5:2907-2912. DOI ScienceOn |
2 | Canaud G, Zuber J, Sberro R, et al. Intensive and prolonged treatment of focal and segmental glomerulosclerosis recurrence in adult kidney transplant recipients: a pilot study. Am J Transplant 2009;9:1081-1086. DOI ScienceOn |
3 | Nam JY, Choi AS, Kim SJ, et al. Rituximab and plasmapheresis for post-transplant recurrence of FSGS. Korean J Nephrol 2010;29:292-295. |
4 | Ohta T, Kawaguchi H, Hattori M, et al. Effect of preand postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children. Transplantation 2001;71:628-633. DOI ScienceOn |
5 | Stewart ZA, Shetty R, Nair R, Reed AI, Brophy PD. Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen. Transplant Proc 2011;43:3994-3996. DOI ScienceOn |
6 | Jeon JM, Oh JS, Kim SM, et al. Combination treatment of rituximab and plasmapheresis in acute cellular rejection with focal segmental glomerular sclerosis after renal transplantation. J Korean Soc Transplant 2010;24:30-34. DOI ScienceOn |
7 | Dello Strologo L, Guzzo I, Laurenzi C, et al. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 2009;88:417-420. DOI ScienceOn |
8 | Rodriguez-Ferrero M, Ampuero J, Anaya F. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Transplant Proc 2009;41:2406-2408. DOI ScienceOn |
9 | Audard V, Kamar N, Sahali D, et al. Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation. Transpl Int 2012;25:e62-e66. DOI ScienceOn |
10 | Fornoni A, Sageshima J, Wei C, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 2011;3:85ra46. |
11 | Cibrik DM, Kaplan B, Campbell DA, Meier-Kriesche HU. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis. Am J Transplant 2003;3:64-67. |
12 | Ryu HJ, Park EC, Sohn TY, Yu SH. Hospital staff and patient recognition toward opening of medical services market, and factors in selecting a foreign hospital. Yonsei Med J 2007;48:184-191. DOI ScienceOn |
13 | Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR. Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 2001;59:328-333. DOI ScienceOn |
14 | Salomon R, Gagnadoux MF, Niaudet P. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation 2003;75:810-814. DOI ScienceOn |
15 | Hariharan S, Adams MB, Brennan DC, et al. Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation 1999;68:635-641. DOI ScienceOn |
16 | Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 2009;87:1232-1239. DOI ScienceOn |
17 | Choi KH, Kim SI, Yoon SY, et al. Long-term outcome of kidney transplantation in adult recipients with focal segmental glomerulosclerosis. Yonsei Med J 2001;42:209-214. DOI ScienceOn |
18 | Pardon A, Audard V, Caillard S, et al. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 2006;21:1053-1059. DOI |
19 | Hwang JH, Han SS, Huh W, et al. Outcome of kidney allograft in patients with adulthood-onset focal segmental glomerulosclerosis: comparison with childhood-onset FSGS. Nephrol Dial Transplant 2012;27:2559-2565. DOI ScienceOn |
20 | Raafat RH, Kalia A, Travis LB, Diven SC. High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 2004;44:50-56. DOI ScienceOn |
21 | Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 1996;334:878-883. DOI ScienceOn |
22 | Laufer J, Ettenger RB, Ho WG, Cohen AH, Marik JL, Fine RN. Plasma exchange for recurrent nephrotic syndrome following renal transplantation. Transplantation 1988;46:540-542. DOI |
23 | Andresdottir MB, Ajubi N, Croockewit S, Assmann KJ, Hibrands LB, Wetzels JF. Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. Nephrol Dial Transplant 1999;14:2650-2656. DOI ScienceOn |
![]() |